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Creatine (Cr) is a nutritional supplement promoting a number of health benefits. Indeed Cr has been shown to be beneficial
in disease-induced muscle atrophy, improve rehabilitation, and afford mild antioxidant activity. The beneficial effects are likely
to derive from pleiotropic interactions. In accord with this notion, we previously demonstrated that multiple pleiotropic effects,
including preservation of mitochondrial damage, account for the capacity of Cr to prevent the differentiation arrest caused by
oxidative stress in C2C12 myoblasts. Given the importance of mitochondria in supporting the myogenic process, here we further
explored the protective effects of Cr on the structure, function, and networking of these organelles in C2C12 cells differentiating
under oxidative stressing conditions; the effects on the energy sensor AMPK, on PGC-1𝛼, which is involved in mitochondrial
biogenesis and its downstream effector Tfam were also investigated. Our results indicate that damage to mitochondria is crucial in
the differentiation imbalance caused by oxidative stress and that the Cr-prevention of these injuries is invariably associated with
the recovery of the normal myogenic capacity. We also found that Cr activates AMPK and induces an upregulation of PGC-1𝛼
expression, two events which are likely to contribute to the protection of mitochondrial quality and function.
1. Introduction
Over the last few decades, the interest in creatine (Cr)
supplementation has increased notably. Cr has been used in
different conditions, not only in improving skeletal muscle
energy homeostasis [1–3] but also as a potential therapeu-
tic agent for subjects suffering from muscle wasting and
myopathies [4–8].
Cr supplementation has been shown to increase satellite
cells and myonuclei number in human skeletal muscle,
especially if associated with contractile activity [9–11]. The
mechanisms by which Cr affects the growth and differ-
entiation of myogenic cells are complex and probably not
yet completely understood [12]. In 1972, Ingwall et al. [13]
reported that Cr increases the expression of myosin heavy
chain and induces muscle-specific protein synthesis in both
skeletal and cardiac chicken myotubes in culture. Previous
works by our group and others on C2C12 myogenic cells
have shown that Cr stimulates growth and protein accretion,
associated with an increase in insulin-like growth factor 1
(IGF-1) mRNA and coordinated upregulation of myogenic
regulatory factors mRNA [14, 15]. In parallel with these
positive effects in normal conditions, we also reported that
pretreatment with Cr, through multiple converging actions,
prevents the inhibition of C2C12 myoblasts’ differentia-
tion into mature myotubes caused by oxidative stress [15].
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The oxidative-dependent actions on C2C12 differentiating
cells leading to a decrease of their cellular viability and to the
myogenic arrest are complex [15, 16]. Among other toxicolog-
ical relevant events, we noticed severe ultrastructural damage
to mitochondria suggesting that they could represent critical
targets of oxidative attack and, interestingly, supplemental
Cr was capable of preserving the integrity of mitochondrial
ultrastructure [15]. In this regard, it is worth noting that Cr
has been shown to protect mitochondria in other cell types
exposed to various stressing conditions [17–19].
A growing body of evidence shows that mitochondria act
as potential regulators of myogenesis and several studies sug-
gest that impairment of mitochondrial structure and activ-
ity blocks myogenic differentiation. Indeed, mitochondrial-
targeting chemicals, such as antimycin, azide, chloram-
phenicol, carbonyl cyanide, m-chlorophenylhydrazone car-
bonyl cyanide, p-(trifluoromethoxy)phenylhydrazone, ethid-
ium bromide, myxothiazol, rotenone, and oligomycin tetra-
cycline [20–30], inhibit the myogenic process. Moreover,
it has been observed that respiration-deficient myoblasts
lacking mitochondrial DNA—rho∘ cells—fail to differenti-
ate into myotubes [22, 23]. Thus, the preservation of the
mitochondrial integrity and functionality in differentiating
myoblasts is necessary to complete the myogenic process in
myotube maturation.
In the present study, we investigated the effect of Cr
on oxidative-induced damage with a particular attention to
mitochondrial ultrastructure, subcellular localization, and
function in the early- (24 h after serum removal, after
exposure to H
2
O
2
) and middifferentiation phase (myotubes
containing more than two nuclei, 48 or 72 h after serum
removal) of myogenesis in C2C12 cells.
Our findings provide insights into the mechanisms
underlying the Cr protection of mitochondrial damage
inflicted by H
2
O
2
intoxication of C2C12 cells and into
the importance of this beneficial effect in preserving their
myogenic capacity.
2. Materials and Methods
2.1. Cell Culture and Treatment Conditions
2.1.1. Cell Culture. C2C12 mouse myoblasts (Sigma-Aldrich,
Italy) were cultured in DMEM (Sigma-Aldrich, Italy) sup-
plemented with 10% v/v fetal bovine serum (Sigma-Aldrich,
Italy), 2mMglutamine (Sigma-Aldrich, Italy), and antibiotics
(50 U/mL penicillin, 50 𝜇g/mL streptomycin, Sigma-Aldrich,
Italy) for 24–48 h to reach 80% of cell confluence. C2C12
cell differentiation was induced by serum withdrawal 1% v/v
(DifferentiatingMedium, DM).Myogenic differentiation was
performed as described in [15]. Cells were observed and
processed for the experiments at critical time intervals, that
is, at selected differentiation days (DifD), which are referred
to in the text as “DifD𝑛,” where “𝑛” is the elapsed time, in
days, from the commencement of differentiation.
2.1.2. Treatment Conditions. Cr preloading of C2C12 was car-
ried out by adding 3mM or 10mM Cr (Creapure, AlzChem,
Germany) to myoblasts over the first 24 h of differentiation.
At this time point (i.e., at the end of DifD1), Cr-supplemented
or Cr-unsupplemented cultures were exposed to 0 or 0.3mM
H
2
O
2
for 1 h in serum-free medium and then cultured in Cr-
and oxidant-free, DM up to day 3 (DifD3), when fusing cells
were forming the first myotubes with more than two nuclei.
Trolox (Sigma-Aldrich, Italy, 0.1mM) was used as a positive
control for the antioxidant effect as described in Sestili
et al. [15]. Aminoimidazole-4-carboxamide ribonucleotide
(AICAR, Sigma-Aldrich, Italy) was used (2mM for 1 h) as a
positive control for AMPK activation [31].
2.1.3. Estimation of Myogenic Index. Themyogenic index was
determined as reported elsewhere [32] and evaluated as the
number of nuclei in myotubes divided by the total number of
nuclei in myoblasts and myotubes. Twenty optical fields were
randomly chosen.
2.1.4. Determination of Cell Viability. Cytotoxicity was deter-
mined using the trypan blue exclusion assay as described in
Sestili et al. [15]. Results were expressed as per cent survival.
2.2. Analysis of Mitochondrial Properties. Mitochondria were
analysed using in situ (permeabilized fixed and live cells) and
in vitro (isolated mitochondria) approaches to study mito-
chondrial morphology, distribution, dynamics, and function
under defined substrate conditions.
2.2.1. Mitochondrial Ultrastructure. For transmission elec-
tron microscopy (TEM) analysis, C2C12 monolayers were
fixed with 2.5% glutaraldehyde in PBS for 5min, gently
scraped, and centrifuged. Pellets were fixed again in a
new fixative solution for 30min, OsO
4
postfixed, alcohol-
dehydrated, and araldite embedded as reported in [33].
Thin sections were collected on nickel 300-mesh grids and
stained with uranyl acetate and lead citrate. The observations
were carried out with a Philips CM10 transmission electron
microscope (FEI Company) at 80KV.
2.2.2. Live Cell Imaging Using Confocal Laser Scanning
Microscopy. For mitochondria and lysosome confocal live
imaging, cells were grown on MatTek glass bottom cham-
bers (MatTek Corporation, Ashland, MA) costained with
100 nMMitoTracker red (MTR, Molecular Probes, Italy) and
500 nM LysoTracker green (LTG, Molecular Probes, Italy)
and incubated for 30min according to Luchetti et al. [34].
The incubation was performed at 37∘C in 5% CO
2
. Labelled
mitochondria were observed by confocal microscopy on a
Leica TCS SP5 II (Leica Microsystems, Italy) instrument and
ImageJ software (NIH, Bethesda, MD).
Each sample was examined through successive opti-
cal slices (0.2mm each) along the 𝑧-axis, and the images
obtained were postprocessed applying Wiener filter decon-
volution. After deconvolution, the images were further pro-
cessed in ImageJ software (NIH, Bethesda, MD) using the
JACoP plug-in for colocalization studies. We used Pearson’s
coefficient as the parameter to measure colocalization in our
samples.
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2.2.3. Mitochondrial Membrane Potential and Mass. Mito-
chondrial membrane potential (ΔΨ) was quantified cytoflu-
orimetrically according to Salucci et al. [35] by measuring
the extent of uptake of the potentiometric dye, tetramethyl
rhodamine methyl ester (TMRE, Sigma-Aldrich, Italy), nor-
malized to MitoTracker Green (MTG), which is taken up by
mitochondria independently of membrane potential. During
the acute exposure to H
2
O
2
at DifD1, myogenic C2C12 cells
were stained with 100 nM MTG for 30min and in the last
15min were coloaded with 50 nM TMRE at 37∘C. Cells
were observed immediately after the oxidative injury. To
verify eventual hyperpolarization in case of mitochondrial
dysfunction, cells were tested for their sensitivity versus
oligomycin, a specific inhibitor of F0-part of H+ ATP syn-
thase, and samples were analysed with and without 5 𝜇M
oligomycin (Sigma-Aldrich, Italy) for 1 h, as described in
Romanello et al. [36]. The protonophore carbonyl cyanide
p-trifluoromethoxyphenylhydrazone (FCC, 4mM) was then
added to the cell culture medium. Fluorescent intensity in
MTG was measured to estimate the overall mitochondrial
mass.
2.2.4. Analysis of Cardiolipin Content/Peroxidation. C2C12
cells were directly labelled in a well with 100 nM 10-N-nonyl
acridine orange (NAO), for 30min at 37∘C in 5% CO
2
. NAO
reflects total mitochondrial mass independently of activity
because it binds to cardiolipin in the mitochondrial mem-
brane. Following incubation, cells were harvested and 300 𝜇L
of fresh medium was added. Changes in mitochondrial fluo-
rescence intensity were analysed by FACScan flow cytometer
equipped with CellQuest software (BD Biosciences, Italy) as
described in [37].
2.2.5. Immunoblotting. Cells were lysed and immunoblotted
as described earlier [15]. Blots were stripped using Restore
Western Blotting Stripping Buffer (Amersham Pharmacia,
Italy) and reprobed if necessary. The following primary
antibodies from Cell Signaling were used: anti-AMPK, anti-
phospho-AMPK (Thr 172), anti-phospho-ACC (Ser 79), and
anti-𝛼-tubulin (Sigma-Aldrich, Italy).
2.2.6. Mitochondrial Biogenesis. Cells cultured and treated
as described above were analysed for the expression of
specific mRNAs at DifD0, DifD1, DifD2, and DifD3. At each
differentiation time, plates were washed with PBS; total DNA
and RNA were extracted from cell cultures using QIAamp
DNA and RNeasy Mini Kit (Qiagen, Germany), respectively,
according to the manufacturer’s instructions. All quantitative
real-time PCR reactions were carried out in the StepOne
Plus (Applied Biosystems, Italy) using 2x SYBR Select Master
Mix (Life Technologies, Italy) and the PCR conditions were
already described in Sestili et al. [15] and Barbieri et al.
[33].The relative gene expressions of peroxisomeproliferator-
activated receptor gamma coactivator 1-alpha (PGC-1𝛼) and
mitochondrial transcription factor A (Tfam) were quantified
using 1𝜇L of cDNA template; the amount of each target
transcript was related to that of the gene encoding riboso-
mal protein S16. The mtDNA/nDNA ratio was obtained as
reported in Barbieri et al. [33], relating the mitochondrial
and nuclear DNA quantities amplifying both COXII and
GAPDH as mtDNA and nDNA targets, respectively. All
oligonucleotide primers have been previously described in
Barbieri et al. [33].
2.2.7. Mitochondrial Proteomic Analysis. Mitochondria from
3 × 10
7 cells were extracted as previously described [33]
and suspended in 8M urea, 4% CHAPS, 65mM DTE, and
40mM Tris base and sonicated for 5 s on ice. Following cen-
trifugation at 21000 g, protein concentration was determined
by Bradford assay [38] and 80 𝜇g of total proteins used for
2-dimensional electrophoresis (2DE). Analytical gels were
stained with silver nitrate [39], while semipreparative gels for
mass spectrometry analysis were stained with Brilliant Blue
R250 (Sigma-Aldrich, USA). Gel images were acquired by
Fluor-S MAX multi-imaging system (Bio-Rad Laboratories
Italy, Segrate, Italy), and the data were analysed with Image-
Master 2D Platinum software. Gel digestion was carried
out according to Shevchenko’s protocol [40] and LC-ESI-
MS/MS analysis was performed using a Q-TOFmicromass
spectrometer (Micromass, UK) as previously described [41].
2.2.8. Statistical Analysis. Unless noted otherwise, the results
were expressed as mean values ± SD. The significance of
differences between the mean values recorded for different
experimental conditions was calculated by Student’s 𝑡-test
and 𝑃 values are indicated where appropriate in the figures
and their legends.
With respect to the determination of ΔΨ, cardiolipin,
AMPK, ACC, PGC-1a, and Tfam levels and mtDNA copy
numbers, the effects of all treatments were tested using a two-
tailed one-way ANOVA analysis. Tukey’s post hoc test was
performed using GraphPad Prism version 5.00 for Windows
(GraphPad Software, USA). The significance threshold was
set to 0.05.
3. Results
3.1. Effects of Cr on Mitochondrial Ultrastructure of H2O2-
Treated C2C12 Cells. The effect of oxidant injury (0.3mM
H
2
O
2
for 1 h) on the viability and myogenic index of C2C12
myoblasts with or without Cr supplementation (3 or 10mM
for 24 h) committed to differentiate was first determined.
Oxidative challenge resulted in a reduction of cell survival
(67.3%±5.3 24 h after intoxication) and in severe inhibition of
myogenic differentiation of surviving cells (with a myogenic
index of 0.081 ± 0.0072 as compared to 0.51 ± 0.047 of
controls): both events could be prevented by 3mM Cr
supplementation (survival of 93.3% ± 8.4 and a myogenic
index of 0.45 ± 0.039). 10mM Cr yielded results not signif-
icantly different as compared to 3mM; therefore, the lower
concentration was used in subsequent experiments.
The effects of supplemental Cr on the mitochondrial
ultrastructural damage in this intoxication setting were then
studiedwithTEM. Figure 1(a) showsTEMmicrographs taken
at DifD1, immediately after oxidative insult; H
2
O
2
treatment
induced severe ultrastructural damage to the majority of
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Figure 1: Protective effect of Cr on oxidant-injuredmitochondria in differentiating C2C12myoblasts. TEMmicrographs and confocal images
were taken immediately after oxidative stress at DifD1. Images were representative of five independent experiments. (a) H
2
O
2
treatment
induced cytoplasmic vacuolization, mitochondrial swelling, and disruption; Cr prevented the effect of H
2
O
2
: Cr-supplemented cells appeared
comparable to the controls, showing lower cytoplasmic vacuolization and numerous elongatedmitochondria with perfectly preserved cristae.
Bar = 2, 1, and 0.5 𝜇m specified in each micrograph. V: vacuole; A: autophagosome; M: mitochondrion. (b) Confocal microscopy of C2C12
myoblasts after double staining with MitoTracker (MTR) and LysoTracker (LTG) showing the mitochondrial network morphology and
lysosome distribution within myocytes and the effect of oxidative challenge with or without Cr supplementation. Bar = 25 𝜇m. (c) Analysis
of confocal images showing the quantification of mitochondrial mass. (d) Number of cells with fragmented mitochondria. (e) Extent of
colocalization of MTR and LTG. Data are the means ± SD. ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01 compared to control (𝑛 = 5).
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the mitochondria, which showed typical matrix swelling and
loss of cristae. Notably, Cr supplementation protected mito-
chondria from these injuries: their number was comparable
to that of controls and they displayed an elongated shape and
well-preserved cristae. We also observed distinctive H
2
O
2
-
mediated cytoplasmic vacuolization, typical of myocytes’
response to oxidative insult [15].We likewise observed several
autophagic vacuoles with double membranes containing
disorganised mitochondrial cristae; sometimes, autophagic
vacuoles occurred close to the sarcolemma. Again, Cr treat-
ment prevented the formation of these cytoplasmic vacuoles.
Going back to viability and myogenic index, according
to previous data [15], addition of Trolox (an established
radical scavenger included as a positive control) resulted in
a qualitatively and quantitatively different protective effect as
compared to Cr against H
2
O
2
challenge, in that it prevented
C2C12 cells’ decrease in viability (cell survival of 91.2% ± 6.4
versus 67.3%±5.3 of H
2
O
2
-only-treated cells) but was unable
to restore their differentiation capacity (a myogenic index of
0.20 ± 0.019 as compared to 0.45 ± 0.039 of H
2
O
2
-injured,
Cr-supplemented cells and 0.51 ± 0.047 of controls).
3.2. Effect of Cr on Mitochondrial Morphology. Confocal
images in Figure 1(b) show filamentous mitochondria with
well-defined tubular shapes in control cells, while H
2
O
2
treatment caused an increase in fragmented, round, and
perinuclear-located mitochondria. Interestingly, Cr preload-
ing prevented these morphological alterations; indeed, mito-
chondria maintained their filamentous and tubular shape
paralleling the myocytes’ elongation axis typical of controls.
Cells preloaded with Cr per se present amitochondrial profile
identical to controls (not shown).
The analysis of the fluorescence intensity of high defi-
nition confocal images allowed us to quantitate mitochon-
drial mass at the early differentiation phase (immediately
after H
2
O
2
insult, DifD1, Figure 1(c)); results demonstrated
a significant decrease of mitochondrial mass in oxidative
damaged myocytes. By contrast, Cr preloading of H
2
O
2
-
treated cells prevented this effect.
Further analysis (see Section 2.2.2) of the above images
showed that, in comparison, H
2
O
2
treatment led to a sig-
nificant increase in the number of fragmented mitochondria
with small perinuclear ring shapes. The cells showing 70%
fragmented or intermediate mitochondria were classified as
fragmented cells [42]; their number increased significantly
upon infliction of oxidative treatment and, not surprisingly,
Cr preloading prevented this effect (Figure 1(d)).
In these oxidative stressing conditions, lysosomes are
likely to be actively involved in the removal of damagedmito-
chondria, as suggested by the appearance of autophagosomes
revealed by TEM (Figure 1(a)). To strengthen this point,
the degree of mitochondria sequestration by lysosomes was
quantified by performing a double staining protocol with
MTR and LTG, followed by quantification of the lysosomal
and mitochondrial overlapping. This analysis showed that
oxidative stress caused intense perinuclear colocalization
of lysosomes with mitochondria (Figure 1(e)), a finding in
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Figure 2: Protective effect of Cr onmitochondrialΔΨ after oxidative
challenge in differentiating C2C12myoblasts.ThemitochondrialΔΨ
(normalized ratio TMRE/MTG) was evaluated immediately after
oxidative stress (DifD1) as the mitochondrial fraction insensitive
to oligomycin. Data are the means ± SD. ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01
compared to control (𝑛 = 5).
line with the ultrastructural TEM observations. Not sur-
prisingly, Cr was found to consistently prevent the lysoso-
mal/mitochondrial colocalization and to preserve the diffuse
localization of lysosomes within the cytoplasm. Notably, the
established bona fide antioxidant Trolox showed a much
weaker protective effect than Cr (not shown). Remarkably,
in Cr-only-supplemented cells, well-preserved, mostly elon-
gated mitochondria could be observed (not shown).
3.3. Effect of Cr on Mitochondrial Membrane Potential.
Mitochondrial membrane potential per mitochondrial unit
was studied cytofluorimetrically at DifD1 determining their
TMRE/MTG ratio, which reflects the extent of ΔΨ, in the
presence of oligomycin (5𝜇M; see Section 2.2.3) [36]. In
particular, our analysis (Figure 2) indicates a significant
reduction of TMRE/MTG ratio (oligomycin-insensitive frac-
tion) in oxidatively injured cells as compared to controls,
an effect that could be prevented by Cr supplementation;
Cr-only-treated myoblasts showed a significant increase in
the TMRE/MTG ratio. Notably, Trolox, unlike Cr, failed to
prevent the loss of ΔΨ in oxidatively injured cells.
3.4. Effect of Cr on Cardiolipin Peroxidation. Flow cytometric
analysis of NAO/cardiolipin interaction (a reliable marker of
mitochondrial oxidative damage) showed that H
2
O
2
treat-
ment caused significant peroxidation of cardiolipin within
24 h after H
2
O
2
challenge (Figure 3), an effect which could
be significantly hampered by Cr, which afforded a 32% pro-
tection rate; Trolox was slightly more effective in preventing
cardiolipin peroxidation.
3.5. Effect of Cr on the Expression of AMPK. Figure 4(a) shows
that Cr preloading increased the extent of phosphorylation
of AMPK and of its downstream firmly established substrate
acetyl-CoA carboxylase (ACC). H
2
O
2
treatment, per se, also
induced AMPK activation, in accordance with literature data
[43]. Interestingly, in Cr-supplemented, oxidatively treated
cells, the increase of AMPK phosphorylation was higher
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Figure 3: Protective effect of Cr on cardiolipin peroxidation induced by oxidative challenge in differentiating C2C12 myoblasts. Flow
cytometric analysis of the cardiolipin-sensitive probe 10-nonyl acridine orange (NAO) was used to monitor changes in mitochondrial lipid
peroxidation in differentiating oxidatively challenged C2C12 cells pretreated with 0 or 3mM Cr. Analysis was performed at DifD2. Data are
the means ± SD. ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01 compared to control (𝑛 = 5).
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Figure 4: Effect of Cr on AMPK. (a) The cell lysates were separated by SDS-PAGE and analysed for pACC, pAMPK, and AMPK protein
expression by Western blotting after the oxidative insult (DifD1); representative images were reported. Blots were also probed for tubulin
protein as loading control. (b) The levels of phosphorylated AMPK versus total AMPK and (c) the levels of phosphorylated ACC versus
tubulin were examined. Data are the mean ± SEM. ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01 compared to control (𝑛 = 4).
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Figure 5: Effect of Cr on mitochondrial biogenesis under normal or oxidatively stressing conditions. mRNA expression level of PGC-1𝛼 (a)
and of Tfam (b) at DifD1; mtDNA content at DifD3 (c). Quantitative analysis of PGC-1𝛼 and Tfam was performed by real-time PCR, and the
amount of each target transcript was related to that of the reference gene (the ribosomal protein S16). The mtDNA content was determined
by real-time PCR and expressed as mtDNA/nDNA ratio (COXII/GAPDH). Data are expressed as the mean ± SEM. ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01
compared to control (𝑛 = 5).
as compared to Cr-only- or H
2
O
2
-only-treated conditions,
suggesting that the two agents act in a somehow additive
fashion. A similar behaviour could be observed with regard
to ACC phosphorylation (Figure 4). It is of note that AICAR,
a reference AMPK activator, induced a robust increase of its
phosphorylation in our cellular setting.
3.6. Effect of Cr on Mitochondrial Biogenesis and mtDNA
Content. PGC-1𝛼 represents a master regulator of mitochon-
drial biogenesis by interacting with several transcription
factors also crucial for maintaining mitochondrial DNA
integrity [44, 45]. Figures 5(a) and 5(b) show the transcription
level of both PGC-1𝛼 and Tfam, quantified using RT real-
time PCR at DifD1. As shown in Figure 5(a), analysis of
C2C12 cells treated with H
2
O
2
or H
2
O
2
+ Cr showed that
their PGC-1𝛼 expression levels were markedly increased as
compared to controls. Similar to PGC-1𝛼, the Tfam expres-
sion level during myoblasts differentiation was characterized
by a tendency to increase (Figure 5(b)) as compared to
controls. MtDNA copy number can be considered as another
marker ofmitochondrial biogenesis and, in general, ofmuscle
health [46]. Our results show that, at DifD3, the relative
mtDNA copy number in Cr-loaded and H
2
O
2
-injured cells
was significantly higher as compared to Cr-free C2C12 cells
exposed to H
2
O
2
(Figure 5(c)).
3.7. Mitochondrial Proteomic Analysis. We next studied the
mitochondrial proteome in C2C12 differentiating myoblasts
using a 2D approach described previously [33].We found that
the 2D profile of H
2
O
2
-injured mitochondria (Figure 6(b))
was significantly different as compared to that of controls
(Figure 6(a)); in particular, a significant reduction—or even
the disappearance—of several proteins could be observed,
especially in the pH range 4–7. By contrast, Cr supple-
mentation afforded a nearly complete protection from these
alterations and produced a protein pattern almost identi-
cal to control (Figure 6(c)), including the proteins whose
expression significantly increases over differentiation [33].
In particular, the increased expression of dihydrolipoamide
dehydrogenase (spot 4) and ATP synthase D chain (spot 7),
both involved in energy production, reflects the capacity of
preserving mitochondrial function.
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Figure 6: Effect of Cr on the mitochondrial proteomic pattern. Mitochondrial proteomic mapping from myogenic C2C12 cells at DifD3; (a)
control cells; (b) H
2
O
2
-treated cells; and (c) Cr-supplemented myocytes treated with H
2
O
2
as in (b).The arrows show differentially expressed
proteins after H
2
O
2
treatment. The major differences in H
2
O
2
-treated cells as compared to (a) and (c) were found in 1 and 2, mitochondrial
aldehyde dehydrogenase-2; 3, protein disulfide isomerase; 4, dihydrolipoamide dehydrogenase; 5, Mn superoxide dismutase; 6, prohibitin;
and 7, ATP synthase D chain. Images were representative of five independent experiments.
4. Discussion
In a previous study, we showed that Cr protects differen-
tiating C2C12 myoblasts from H
2
O
2
-dependent myogenic
arrest [15] and that in oxidative stressing conditions, Cr,
through multiple and converging mechanisms (increased
expression of myogenic factors and of IGF-1, reduction of
GSH consumption and of cell death through its antioxidant
activity, and amelioration and preservation of cellular energy
charge through increased availability of Cr Phosphate, CrP),
might providemyoblasts with an enhanced adaptive potential
resulting in the preservation of myogenic capacity.
Here, we demonstrate that Cr effectively and invariably
protects mitochondrial structure and function of differenti-
ating myoblasts from the damage inflicted by exogenously
addedH
2
O
2
(0.3mM for 1 h, DifD1), providing novel insights
into the cellular mechanisms of Cr in preventing the myo-
genic arrest caused by oxidative challenge.
Among the cellular targets of oxidative attack, ultrastruc-
tural TEM analysis showed and confirmed that mitochondria
appear to be seriously damaged and, interestingly, Cr was
capable of preserving their integrity. Mitochondria have
been recognized as crucial players in myogenesis, and a
considerable body of evidence suggests that impairment of
their subcellular organisation and activity blocks myogenic
differentiation [15, 26, 30, 47, 48]. Our data further confirm
this notion and also highlight the importance of preserving
mitochondrial integrity in this differentiation process.
We adopted a morphofunctional and biochemical
approach to study the mitochondrial structural organisation,
specific mitochondria-targeted signaling induced by Cr, and
other related functions using the C2C12 myogenic cellular
model.
We found that oxidative insult induced multiple damage
to muscle mitochondria, such as ultrastructural loss of
cristae, osmotic swelling, networking destruction, decrease in
mitochondrial mass, mitochondrial impaired function (ΔΨ),
reduction of mtDNA copy number, increase in cardiolip-
inperoxidation, and quantitative modification of mitochon-
drial protein expression pattern. With regard to the fate of
oxidatively damaged mitochondria, a significant proportion
was irreversibly removed by lysosomal activation, an event
that has been previously described [49]. Cr supplementation
prevented these severe ROS-dependent injuries and alter-
ations and preservedmitochondrial integrity, biogenesis, and
function, and, notably, protection of mitochondria invariably
coincided with the restoration of myoblast differentiation
under oxidative stressing conditions.
In particular, confocal microscopy/image analyses
showed that supplemental Cr preserved mitochondrial mor-
phology, single unit integrity, and networking immediately
after oxidative insult. Importantly, the prompt assembly of
elongated mitochondrial networks is a necessary condition
for mitochondrial biogenesis, and both events are critically
involved in myoblast differentiation [48]. Hence, the Cr-
mediated reduction of the mitochondrial network frag-
mentation reflects the efficacy of its protective potential.
The abovementioned protective effects promoted by Cr
are likely to depend on multiple mechanisms, a notion in
line with the well-established Cr pleiotropism [3, 12, 50–52].
For instance, the lower degree of H
2
O
2
-inflicted cardiolipin
peroxidation, a marker of mitochondrial oxidative damage
[53], is conceivable with the direct antioxidant capacity of
Cr [15, 16], and indeed also Trolox reduces the extent of
cardiolipin peroxidation. However, according to previous
data [15], the antioxidant capacity alone is a condition which
may favour cell survival but is insufficient to fully protect cells
from myogenic arrest: such a conclusion can be drawn from
the observation that Trolox-loadedH
2
O
2
-injuredC2C12 cells
are unable to complete the differentiation task. Thus, the
effects promoted by Cr are more complex as compared to
those of a mere bona fide antioxidant and can be explained
on the basis of its established pleiotropism [3, 12, 50, 52].
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Similarly, another central event is the Cr-related mainte-
nance of the mitochondrial ΔΨ (Figure 2), that is, mitochon-
drial function, which in turn may depend on its antioxidant
effect; the contribution to an increased cellular energy charge
and utilization through the larger availability of CrP [15];
the stabilization of mitochondrial Cr kinase in its active
octameric form, which is known to consolidate the structure
of mitochondrial membranes and increase their resistance to
ROS or hypoxia [3, 54]; and the protection of mitochondrial
permeability transition pore complex [55].
The Cr-dependent preservation of mitochondrial
integrity and function in oxidatively injured cells is further
supported by the 2D mt-protein analysis. Mitochondria
purified from oxidatively injured cells at DifD3 had a protein
profile similar to that observed in mitochondria from
undifferentiated myoblasts, pointing to the H
2
O
2
-related
myogenic inhibition, while Cr supplementation resulted
in a protein pattern highly similar to that of normally dif-
ferentiating myoblasts.
In this study, we highlighted a further mechanism which
may significantly contribute to the mitochondrially oriented
Cr effects, namely, the activation ofAMPK.AMPK is a pivotal
energy sensor playing a central role in linking mitochondrial
function to cellular metabolism [43, 56–59]. It is widely
accepted that its pharmacological activation in restingmuscle
has deep effects on the expression of an array of genes
related to mitochondrial biogenesis and function [60–62].
In our intoxication/protection paradigm, AMPK activation
is complex since it is promoted by both H
2
O
2
and Cr.
In the case of H
2
O
2
, it activates AMPK per se, an event
that might constitute a physiological response to ROS in an
attempt to counteract the differentiation arrest through the
induction of an adaptive pathway promoting, for example,
mitochondrial biogenesis and oxidative metabolism, both
functionally oriented to better energy recovery and home-
ostasis (see also below). However, despite this attempt, cells
undergo complete differentiation arrest, suggesting that this
cellular response is per se insufficient to counteract this
stress.
According to previous reports by other groups [57, 58],
here we report that Cr per se caused increased phosphoryla-
tion of AMPK (31% ± 2.7). More interestingly, this increase
seems to be additive to that promoted by H
2
O
2
(25% ±
4.71); indeed, in Cr-supplemented cells exposed to oxidative
stress, AMPK phosphorylation increased by 66% ± 7.10, a
condition that coincides with the recovery of a quasi-normal
myogenic ability. Thus, it is conceivable that the sum of
these two distinct AMPK activation instances, along with the
other Cr benefits, is sufficient to significantly help cells to
overcome the differentiative arrest imposed byH
2
O
2
. In other
words, the increased and cumulative activation ofAMPKmay
represent another relevant feature of Cr-pleiotropic nature,
which concurs with the rescue of the differentiation capacity.
In this regard, it is worth noting that although the role
of AMPK phosphorylation in the myogenic process is not
yet fully understood [12, 52], Fu et al. [59] described that
transient AMPK activation by AICAR resulted in myogenin
increase, promoting myogenesis in C2C12 cells. Incidentally,
we too reported [15] an increase of myogenin upon Cr
supplementation in the same differentiation setting as in the
present study.
Moreover, here we also assessed the gene expression level
of the “master” regulator of the mitochondrial biogenesis,
namely, PGC-1𝛼 and Tfam, regulated by PGC-1𝛼, required
for mitochondrial biogenesis, which mirrors the changing
levels of mtDNA in the cell and plays a crucial role in
mtDNA maintenance [63, 64]. In particular, the expression
level of these two transcription factors increased under all
the conditions tested, as compared to controls, and may
reflect a behaviour that is functionally convergent to that
seen for AMPK. Hence, they may play a role in the promo-
tion of mitochondrial biogenesis under oxidative stressing
conditions and, in turn, in the restoration of the myogenic
capacity.MitochondrialDNAcopy number reflects the extent
of mitochondrial biogenesis, whose variations can be better
appreciated at later differentiation times (i.e., DifD3). As
expected, oxidative stress caused a significant reduction of
mtDNA copies; Cr per se slightly increased mtDNA content
according to its prodifferentiation capacity [12] and, more
interestingly, prevented the drastic reduction of mtDNA
caused by oxidative stress.
Data presented herein also indicate that Cr per se induces
significantmodifications of some parameters directly or indi-
rectly associated with mitochondrial content and function,
such as increased mtDNA copies, ΔΨ, AMPK phosphory-
lation, PGC-1𝛼 expression, and a slight augmentation of
mitochondrial mass: these effects are likely to be involved in
the well known anabolic action of Cr in skeletal muscle [12].
5. Conclusions
On thewhole, our results highlight that AMPKactivation and
PGC-1𝛼 upregulation could be important for maintaining the
myogenic wave and differentiation even in adverse stressing
conditions such as oxidative insult. These effects could repre-
sent an important mechanism contributing to the benefits of
supplemental Cr in those muscular diseases, where oxidative
stress, mitochondrial impairment, and differentiative imbal-
ance play a causative role, for example, muscular dystrophies,
mitochondrial cytopathies, aging, disuse atrophy, and sar-
copenia [6–8, 65].
In this study, we have identified a wide range of con-
verging mitochondrial positive effects of Cr in C2C12 cells
differentiating under normal or oxidative stressing condi-
tions, which contribute to Cr pleiotropism at the basis of its
myogenic and protective activities.
Indeed, these mitochondrial effects are likely to concur
with the other cellular actions that we and others have
identified as important in supporting the myogenic process
and protecting its execution from oxidative insult, such as the
mild direct antioxidant activity [16, 50], ameliorated cellular
energy [15, 54], increased expression of muscle regulatory
factors and of IGF-1 [15], decreased apoptotic susceptibility,
and cell death [3].
Together, these conditions jointly favour protection and
rapid mitochondrial recovery minimizing the effects of
oxidative damage, thus restoring myogenesis.
10 Oxidative Medicine and Cellular Longevity
Competing Interests
The authors declare that there are no competing interests.
Acknowledgments
The authors wish to thank Professor Timothy Bloom, Centro
Linguistico di Ateneo of the University of Urbino Carlo Bo,
for critically reading the paper and Dr. Ulrike Braun, from
AlzChem, for kindly providing Creapure.
References
[1] P. L. Greenhaff, A. Casey, A. H. Short, R. Harris, K. Soderlund,
and E. Hultman, “Influence of oral creatine supplementation
of muscle torque during repeated bouts of maximal voluntary
exercise in man,” Clinical Science, vol. 84, no. 5, pp. 565–571,
1993.
[2] P. D. Balsom, K. So¨derlund, B. Sjo¨din, and B. Ekblom, “Skeletal
muscle metabolism during short duration high-intensity exer-
cise: influence of creatine supplementation,” Acta Physiologica
Scandinavica, vol. 154, no. 3, pp. 303–310, 1995.
[3] T. Wallimann, M. Tokarska-Schlattner, and U. Schlattner, “The
creatine kinase system and pleiotropic effects of creatine,”
Amino acids, vol. 40, no. 5, pp. 1271–1296, 2011.
[4] M.Tarnopolsky and J.Martin, “Creatinemonohydrate increases
strength in patients with neuromuscular disease,” Neurology,
vol. 52, no. 4, pp. 854–857, 1999.
[5] A. Louis, J. Lebacq, J. R. Poortmans et al., “Beneficial effects of
creatine supplementation in dystrophic patients,” Muscle and
Nerve, vol. 27, no. 5, pp. 604–610, 2003.
[6] M. A. Tarnopolsky, “Clinical use of creatine in neuromuscular
and neurometabolic disorders,” Sub-Cellular Biochemistry, vol.
46, pp. 183–204, 2007.
[7] R. A. Kley, M. A. Tarnopolsky, and M. Vorgerd, “Creatine for
treatingmuscle disorders,”TheCochrane Database of Systematic
Reviews, no. 6, Article ID CD004760, 2013.
[8] G. D’Antona, S. M. Nabavi, P. Micheletti et al., “Creatine, L-
carnitine, and 𝜔 3 polyunsaturated fatty acid supplementation
from healthy to diseased skeletal muscle,” BioMed Research
International, vol. 2014, Article ID 613890, 16 pages, 2014.
[9] S. Olsen, P. Aagaard, F. Kadi et al., “Creatine supplementation
augments the increase in satellite cell and myonuclei number
in human skeletal muscle induced by strength training,” The
Journal of Physiology, vol. 573, no. 2, pp. 525–534, 2006.
[10] M. C. Devries and S. M. Phillips, “Creatine supplementation
during resistance training in older adults—a meta-analysis,”
Medicine and Science in Sports and Exercise, vol. 46, no. 6, pp.
1194–1203, 2014.
[11] J. Kim, J. Lee, S. Kim, D. Yoon, J. Kim, and D. J. Sung, “Role of
creatine supplementation in exercise-induced muscle damage:
a mini review,” Journal of Exercise Rehabilitation, vol. 11, no. 5,
pp. 244–250, 2015.
[12] P. Sestili, E. Barbieri, and V. Stocchi, “Effects of creatine in
skeletal muscle cells and in myoblasts differentiating under
normal or oxidatively stressing conditions,” Mini-Reviews in
Medicinal Chemistry, vol. 16, no. 1, pp. 4–11, 2015.
[13] J. S. Ingwall, M. F. Morales, and F. E. Stockdale, “Creatine
and the control of myosin synthesis in differentiating skeletal
muscle,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 69, no. 8, pp. 2250–2253, 1972.
[14] M. Louis, R. Van Beneden, M. Dehoux, J. P. Thissen, and M.
Francaux, “Creatine increases IGF-I and myogenic regulatory
factor mRNA in C
2
C
12
cells,” FEBS Letters, vol. 557, no. 1–3, pp.
243–247, 2004.
[15] P. Sestili, E. Barbieri, C. Martinelli et al., “Creatine supple-
mentation prevents the inhibition of myogenic differentiation
in oxidatively injured C2C12 murine myoblasts,” Molecular
Nutrition & Food Research, vol. 53, no. 9, pp. 1187–1204, 2009.
[16] P. Sestili, C. Martinelli, G. Bravi et al., “Creatine supplemen-
tation affords cytoprotection in oxidatively injured cultured
mammalian cells via direct antioxidant activity,” Free Radical
Biology & Medicine, vol. 40, no. 5, pp. 837–849, 2006.
[17] M. Berneburg, T. Gremmel, V. Ku¨rten et al., “Creatine sup-
plementation normalizes mutagenesis of mitochondrial DNA
as well as functional consequences,” Journal of Investigative
Dermatology, vol. 125, no. 2, pp. 213–220, 2005.
[18] H. Lenz,M. Schmidt,V.Welge et al., “The creatine kinase system
in human skin: protective effects of creatine against oxidative
and UV damage in vitro and in vivo,” Journal of Investigative
Dermatology, vol. 124, no. 2, pp. 443–452, 2005.
[19] C. Guidi, L. Potenza, P. Sestili et al., “Differential effect of cre-
atine on oxidatively-injured mitochondrial and nuclear DNA,”
Biochimica et Biophysica Acta—General Subjects, vol. 1780, no.
1, pp. 16–26, 2008.
[20] C. F. Brunk and D. Yaffe, “The reversible inhibition of myoblast
fusion by ethidium bromide (EB),” Experimental Cell Research,
vol. 99, no. 2, pp. 310–318, 1976.
[21] W. Korohoda, Z. Pietrzkowski, and K. Reiss, “Chlorampheni-
col, an inhibitor of mitochondrial protein synthesis, inhibits
myoblast fusion and myotube differentiation,” Folia Histochem-
ica et Cytobiologica, vol. 31, no. 1, pp. 9–13, 1993.
[22] N. H. Herzberg, E. Middelkoop, M. Adorf et al., “Mitochondria
in cultured human muscle cells depleted of mitochondrial
DNA,” European Journal of Cell Biology, vol. 61, no. 2, pp. 400–
408, 1993.
[23] N. H. Herzberg, R. Zwart, R. A. Wolterman et al., “Dif-
ferentiation and proliferation of respiration-deficient human
myoblasts,” Biochimica et Biophysica Acta (BBA)—Molecular
Basis of Disease, vol. 1181, no. 1, pp. 63–67, 1993.
[24] S. C. Leary, B. J. Battersby, R. G. Hansford, and C. D. Moyes,
“Interactions between bioenergetics andmitochondrial biogen-
esis,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1365, no.
3, pp. 522–530, 1998.
[25] G. Biswas, O. A. Adebanjo, B. D. Freedman et al., “Retrograde
Ca2+ signaling in C2C12 skeletal myocytes in response to
mitochondrial genetic and metabolic stress: a novel mode of
inter-organelle crosstalk,”The EMBO Journal, vol. 18, no. 3, pp.
522–533, 1999.
[26] P. Rochard, A. Rodier, F. Casas et al., “Mitochondrial activity is
involved in the regulation of myoblast differentiation through
myogenin expression and activity of myogenic factors,” The
Journal of Biological Chemistry, vol. 275, no. 4, pp. 2733–2744,
2000.
[27] S. C. Leary, B. C.Hill, C.N. Lyons et al., “Chronic treatmentwith
azide in situ leads to an irreversible loss of cytochrome c oxidase
activity via holoenzyme dissociation,” The Journal of Biological
Chemistry, vol. 277, no. 13, pp. 11321–11328, 2002.
[28] Z. Yun, Q. Lin, and A. J. Giaccia, “Adaptive myogenesis under
hypoxia,” Molecular and Cellular Biology, vol. 25, no. 8, pp.
3040–3055, 2005.
[29] P. Pawlikowska, B. Gajkowska, J.-F. Hocquette, and A. Orze-
chowski, “Not only insulin stimulates mitochondriogenesis in
Oxidative Medicine and Cellular Longevity 11
muscle cells, but mitochondria are also essential for insulin-
mediated myogenesis,” Cell Proliferation, vol. 39, no. 2, pp. 127–
145, 2006.
[30] P. Seyer, S. Grandemange, M. Busson et al., “Mitochondrial
activity regulates myoblast differentiation by control of c-Myc
expression,” Journal of Cellular Physiology, vol. 207, no. 1, pp. 75–
86, 2006.
[31] N. Nakai, F. Kawano, and K. Nakata, “Mechanical stretch
activates mammalian target of rapamycin and AMP-activated
protein kinase pathways in skeletal muscle cells,”Molecular and
Cellular Biochemistry, vol. 406, pp. 1–8, 2015.
[32] P. Ferri, E. Barbieri, S. Burattini et al., “Expression and sub-
cellular localization of myogenic regulatory factors during the
differentiation of skeletal muscle C2C12 myoblasts,” Journal of
Cellular Biochemistry, vol. 108, no. 6, pp. 1302–1317, 2009.
[33] E. Barbieri, M. Battistelli, L. Casadei et al., “Morphofunc-
tional and biochemical approaches for studying mitochondrial
changes during myoblasts differentiation,” Journal of Aging
Research, vol. 2011, Article ID 845379, 16 pages, 2011.
[34] F. Luchetti, B. Canonico, E. Cesarini et al., “7-Ketocholesterol
and 5,6-secosterol induce human endothelial cell dysfunction
by differential mechanisms,” Steroids, vol. 99, article no. 7740,
pp. 204–211, 2015.
[35] S. Salucci, S. Burattini, V. Baldassarri et al., “The peculiar
apoptotic behavior of skeletal muscle cells,” Histology and
Histopathology, vol. 28, no. 8, pp. 1073–1087, 2013.
[36] V. Romanello, E. Guadagnin, L. Gomes et al., “Mitochondrial
fission and remodelling contributes to muscle atrophy,” The
EMBO Journal, vol. 29, no. 10, pp. 1774–1785, 2010.
[37] F. Luchetti, B. Canonico, F. Mannello et al., “Melatonin reduces
early changes in intramitochondrial cardiolipin during apopto-
sis in U937 cell line,” Toxicology in Vitro, vol. 21, no. 2, pp. 293–
301, 2007.
[38] M. M. Bradford, “A rapid and sensitive method for the quanti-
tation of microgram quantities of protein utilizing the principle
of protein-dye binding,”Analytical Biochemistry, vol. 72, no. 1-2,
pp. 248–254, 1976.
[39] P. Sinha, J. Poland, M. Schno¨lzer, and T. Rabilloud, “A new
silver staining apparatus and procedure formatrix-assisted laser
desorption/ionization-time of flight analysis of proteins after
two-dimensional electrophoresis,” Proteomics, vol. 1, no. 7, pp.
835–840, 2001.
[40] A. Shevchenko, M. Wilm, O. Vorm, and M. Mann, “Mass
spectrometric sequencing of proteins from silver-stained poly-
acrylamide gels,” Analytical Chemistry, vol. 68, no. 5, pp. 850–
858, 1996.
[41] M. Guescini, D. Guidolin, L. Vallorani et al., “C2C12 myoblasts
release micro-vesicles containing mtDNA and proteins
involved in signal transduction,” Experimental Cell Research,
vol. 316, no. 12, pp. 1977–1984, 2010.
[42] K. Peng, Y. Tao, J. Zhang et al., “Resveratrol regulates
mitochondrial biogenesis and fission/fusion to attenuate
rotenone-induced neurotoxicity,” Oxidative Medicine and
Cellular Longevity, vol. 2016, Article ID 6705621, 12 pages, 2016.
[43] C. Handschin and B. M. Spiegelman, “Peroxisome proliferator-
activated receptor 𝛾 coactivator 1 coactivators, energy home-
ostasis, and metabolism,” Endocrine Reviews, vol. 27, no. 7, pp.
728–735, 2006.
[44] M. A. Parisi andD. A. Clayton, “Similarity of humanmitochon-
drial transcription factor 1 to high mobility group proteins,”
Science, vol. 252, no. 5008, pp. 965–969, 1991.
[45] M. Falkenberg, M. Gaspari, A. Rantanen, A. Trifunovic, N.-G.
Larsson, and C. M. Gustafsson, “Mitochondrial transcription
factors B1 and B2 activate transcription of human mtDNA,”
Nature Genetics, vol. 31, no. 3, pp. 289–294, 2002.
[46] E. Barbieri, D. Agostini, E. Polidori et al., “The pleiotropic effect
of physical exercise onmitochondrial dynamics in aging skeletal
muscle,” Oxidative Medicine and Cellular Longevity, vol. 2015,
Article ID 917085, 15 pages, 2015.
[47] P. Seyer, S. Grandemange, P. Rochard et al., “P43-dependent
mitochondrial activity regulates myoblast differentiation and
slow myosin isoform expression by control of Calcineurin
expression,” Experimental Cell Research, vol. 317, no. 14, pp.
2059–2071, 2011.
[48] A. Wagatsuma and K. Sakuma, “Mitochondria as a potential
regulator of myogenesis,”The ScientificWorld Journal, vol. 2013,
Article ID 593267, 9 pages, 2013.
[49] W.-X. Ding and X.-M. Yin, “Mitophagy: mechanisms, patho-
physiological roles, and analysis,” Biological Chemistry, vol. 393,
no. 7, pp. 547–564, 2012.
[50] P. Sestili, C. Martinelli, E. Colombo et al., “Creatine as an
antioxidant,” Amino Acids, vol. 40, no. 5, pp. 1385–1396, 2011.
[51] S. Sartini, D. Lattanzi, P. Ambrogini et al., “Maternal creatine
supplementation affects themorpho-functional development of
hippocampal neurons in rat offspring,” Neuroscience, vol. 312,
pp. 120–129, 2016.
[52] P. Sestili, P. Ambrogini, E. Barbieri et al., “New insights into the
trophic and cytoprotective effects of creatine in in vitro and in
vivo models of cell maturation,” Amino Acids, 2016.
[53] G. Paradies, G. Petrosillo, M. Pistolese, and F. M. Ruggiero,
“Reactive oxygen species affect mitochondrial electron trans-
port complex I activity through oxidative cardiolipin damage,”
Gene, vol. 286, no. 1, pp. 135–141, 2002.
[54] T. Wallimann, “Introduction—creatine: cheap ergogenic sup-
plement with great potential for health and disease,” Sub-
Cellular Biochemistry, vol. 46, pp. 1–16, 2007.
[55] M. Dolder, B.Walzel, O. Speer, U. Schlattner, and T.Wallimann,
“Inhibition of the mitochondrial permeability transition by
creatine kinase substrates. Requirement formicrocompartmen-
tation,”The Journal of Biological Chemistry, vol. 278, no. 20, pp.
17760–17766, 2003.
[56] S. Jager, C. Handschin, J. St-Pierre, and B. M. Spiegelman,
“AMP-activated protein kinase (AMPK) action in skeletal mus-
cle via direct phosphorylation of PGC-1𝛼,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 104, no. 29, pp. 12017–12022, 2007.
[57] R. B. Ceddia and G. Sweeney, “Creatine supplementation
increases glucose oxidation and AMPK phosphorylation and
reduces lactate production in L6 rat skeletal muscle cells,” The
Journal of Physiology, vol. 555, no. 2, pp. 409–421, 2004.
[58] C. R. R. Alves, J. C. Ferreira, M. A. De Siqueira-Filho, C. R.
Carvalho, A. H. Lancha Jr., and B. Gualano, “Creatine-induced
glucose uptake in type 2 diabetes: arole for AMPK-𝛼?” Amino
Acids, vol. 43, no. 4, pp. 1803–1807, 2012.
[59] X. Fu, J.-X. Zhao,M.-J. Zhu et al., “AMP-activated protein kinase
𝛼1 but not 𝛼2 catalytic subunit potentiates myogenin expression
andmyogenesis,”Molecular and Cellular Biology, vol. 33, no. 22,
pp. 4517–4525, 2013.
[60] G. R. Steinberg and B. E. Kemp, “AMPK in health and disease,”
Physiological Reviews, vol. 89, no. 3, pp. 1025–1078, 2009.
[61] S. Fogarty and D. G. Hardie, “Development of protein kinase
activators: AMPK as a target inmetabolic disorders and cancer,”
12 Oxidative Medicine and Cellular Longevity
Biochimica et Biophysica Acta—Proteins and Proteomics, vol.
1804, no. 3, pp. 581–591, 2010.
[62] K.A. Coughlan, R. J. Valentine,N. B. Ruderman, andA.K. Saha,
“AMPK activation: a therapeutic target for type 2 diabetes?”
Diabetes, Metabolic Syndrome and Obesity: Targets andTherapy,
vol. 7, pp. 241–253, 2014.
[63] M. I. Ekstrand, M. Falkenberg, A. Rantanen et al., “Mitochon-
drial transcription factor A regulates mtDNA copy number in
mammals,” Human Molecular Genetics, vol. 13, no. 9, pp. 935–
944, 2004.
[64] H.-C. Lee and Y.-H. Wei, “Mitochondrial biogenesis and
mitochondrial DNA maintenance of mammalian cells under
oxidative stress,” The International Journal of Biochemistry &
Cell Biology, vol. 37, no. 4, pp. 822–834, 2005.
[65] M. A. Tarnopolsky, “Creatine as a therapeutic strategy for
myopathies,” Amino Acids, vol. 40, no. 5, pp. 1397–1407, 2011.
